Module delivery
Part time delivery, with the module delivered in one semester. The module runs in semester one.
Key dates and application information
Apply by: 31st July 2024.
Module start date (1): 4th September 2024.
Module end date (1): 6th September 2024.
Module start date (2): 9th September 2024.
Module end date (2): 11th September 2024.
Module overview
To critically evaluate and demonstrate competency in the management and care of patients with solid and haematological tumours receiving systemic anti-cancer therapies (SACT).
Who is the module for?
The module is designed for practising, registered healthcare professionals. The module is a standalone option which can be used to support continuous professional development.
Module details and indicative content
Learners will evaluate the decision making, risk assessment and therapeutic intervention in relation to the management and holistic care of the patient receiving SACT.
You will also examine the professional policy, health and safety regulations and legal aspects relating to the administration of systemic anti-cancer therapy and reflect critically on own professional and clinical skill development.
Additionally, you will an analyse the pharmacological properties of anti-cancer drugs and critically evaluate the physiological impact of systemic anti-cancer therapies including chemotherapeutic agents on individuals.
How you are assessed
There are three summative assessments:
- One practical assessment – a production of a Clinical Practice Competency Portfolio
- A 1500-word critical reflection
- A 90-minute written examination based on Online Structured Clinical Exam (OSCE) Clinical Scenario